Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Selectimmune Pharma AB | 2,203,000 | net | 09 Dec 2020 | tx 3+2,203,000 |
| Hamlet BioPharma AB | 38,654 | net | 26 Mar 2026 | tx 2+38,654 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Mar 2026 | PURCHASE | Hamlet BioPharma AB | 25,000 | 6.98 SEK | first after silence |
| 17 Mar 2026 | OTHER | Hamlet BioPharma AB | 13,654 | 0.00 SEK | |
| 09 Dec 2020 | PURCHASE | Selectimmune Pharma AB | 3,000 | 13.51 SEK | first after silence |
| 08 Nov 2019 | PURCHASE | Selectimmune Pharma AB | 200,000 | 15.50 SEK | |
| 14 Jun 2019 | LENDING | Selectimmune Pharma AB | 2,000,000 | 7.50 SEK |
2 purchases reported after at least 12 months of silence — most recent on 26 Mar 2026.